Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone vs Continuous Aspiration of Subglottic Content for Prevention of Ventilator-Associated Pneumonia
NCT00374959Phase 4Completed
- Sponsor
- Hospital Universitario Príncipe de Asturias
- Start
- Oct 2000
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ceftriaxone in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Hospital Universitario Príncipe de Asturias. Primary endpoint: Cumulative incidence of early-onset ventilator-associated pneumonia. Started Oct 2000; status: completed.
02
Drugs
ceftriaxone
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00374959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374959.